User profiles for Jagpreet Chhatwal
Jagpreet ChhatwalHarvard Medical School, Massachusetts General Hospital Verified email at mgh.harvard.edu Cited by 6787 |
Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States
J Chhatwal, F Kanwal, MS Roberts… - Annals of internal …, 2015 - acpjournals.org
Background: Sofosbuvir and ledipasvir, which have recently been approved for treatment of
chronic hepatitis C virus (HCV) infection, are more efficacious and safer than the old …
chronic hepatitis C virus (HCV) infection, are more efficacious and safer than the old …
Ensemble forecasts of coronavirus disease 2019 (COVID-19) in the US
Background The COVID-19 pandemic has driven demand for forecasts to guide policy and
planning. Previous research has suggested that combining forecasts from multiple models …
planning. Previous research has suggested that combining forecasts from multiple models …
Prevention of prescription opioid misuse and projected overdose deaths in the United States
…, PV Pandharipande, J Chhatwal - JAMA network …, 2019 - jamanetwork.com
Importance Deaths due to opioid overdose have tripled in the last decade. Efforts to curb
this trend have focused on restricting the prescription opioid supply; however, the near-term …
this trend have focused on restricting the prescription opioid supply; however, the near-term …
Comparison of logistic regression and artificial neural network models in breast cancer risk estimation
Computer models in medical diagnosis are being developed to help physicians differentiate
between healthy patients and patients with disease. These models can aid in successful …
between healthy patients and patients with disease. These models can aid in successful …
Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration
BACKGROUND: Discriminating malignant breast lesions from benign ones and accurately
predicting the risk of breast cancer for individual patients are crucial to successful clinical …
predicting the risk of breast cancer for individual patients are crucial to successful clinical …
Effect of increased alcohol consumption during COVID‐19 pandemic on alcohol‐associated liver disease: a modeling study
Background and Aims Alcohol consumption increased during the COVID‐19 pandemic in
2020 in the United States. We projected the effect of increased alcohol consumption on alcohol…
2020 in the United States. We projected the effect of increased alcohol consumption on alcohol…
Prevention of hepatitis C by screening and treatment in US prisons
Background: The prevalence of hepatitis C virus (HCV) in US prisoners is high; however,
HCV testing and treatment are rare. Infected inmates released back into society contribute to …
HCV testing and treatment are rare. Infected inmates released back into society contribute to …
[HTML][HTML] Economic burden of chronic lymphocytic leukemia in the era of oral targeted therapies in the United States
…, MJ Keating, HM Kantarjian, J Chhatwal - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Purpose Oral targeted therapies represent a significant advance for the treatment of patients
with chronic lymphocytic leukemia (CLL); however, their high cost has raised concerns …
with chronic lymphocytic leukemia (CLL); however, their high cost has raised concerns …
[PDF][PDF] Hepatitis C disease burden in the United States in the era of oral direct‐acting antivirals
Oral direct‐acting antivirals (DAAs) represent a major advance in hepatitis C virus (HCV)
treatment. Along with recent updates in HCV screening policy and expansions in insurance …
treatment. Along with recent updates in HCV screening policy and expansions in insurance …
The changing burden of hepatitis C virus infection in the United States: model-based predictions
Background: Chronic hepatitis C virus (HCV) infection causes a substantial health and
economic burden in the United States. With the availability of direct-acting antiviral agents, …
economic burden in the United States. With the availability of direct-acting antiviral agents, …